Vasomotor Symptoms Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Vasomotor Symptoms Market is segmented By Treatment (Hormone Therapy, Non-hormonal Medications, Lifestyle Modifications, Behavioral Therapies), By Rou....
Vasomotor Symptoms Market Size
Market Size in USD
CAGR6.8%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 6.8% |
| Market Concentration | High |
| Major Players | Therapeutics MD, Mithra Pharmaceuticals, KaNDy Pharmaceuticals, Fervent Pharmaceuticals, Astellas Pharma |
please let us know !
Vasomotor Symptoms Market Analysis
The Vasomotor Symptoms Market is estimated to be valued at USD 3.71 billion in 2024 and is expected to reach USD 6.40 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031. The growing geriatric female population experiencing menopause worldwide is one of the key factors driving the demand for treatment of vasomotor symptoms such as hot flashes and night sweats.
The market is witnessing increased adoption of therapeutics such as Estradiol and Prempro that offer effective relief from vasomotor symptoms. Moreover, there is a rising trend of combination therapy using these drugs along with other supplements and lifestyle modifications for addressing vasomotor symptoms. With the availability of various prescription drugs and supplements, more women are seeking medical treatment for managing vasomotor symptoms triggered by menopause.